Free Trial

Inogen (INGN) Competitors

Inogen logo
$9.16
+0.13 (+1.44%)
(As of 03:39 PM ET)

INGN vs. ZJYL, SMTI, LAKE, NTRB, APT, MLSS, COCH, RBOT, CLGN, and SPAI

Should you be buying Inogen stock or one of its competitors? The main competitors of Inogen include Jin Medical International (ZJYL), Sanara MedTech (SMTI), Lakeland Industries (LAKE), Nutriband (NTRB), Alpha Pro Tech (APT), Milestone Scientific (MLSS), Envoy Medical (COCH), Vicarious Surgical (RBOT), CollPlant Biotechnologies (CLGN), and Safe Pro Group Inc. Common Stock (SPAI). These companies are all part of the "surgical appliances & supplies" industry.

Inogen vs.

Jin Medical International (NASDAQ:ZJYL) and Inogen (NASDAQ:INGN) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, risk, earnings, media sentiment, profitability, dividends, valuation and institutional ownership.

In the previous week, Inogen had 2 more articles in the media than Jin Medical International. MarketBeat recorded 2 mentions for Inogen and 0 mentions for Jin Medical International. Inogen's average media sentiment score of 0.55 beat Jin Medical International's score of 0.00 indicating that Inogen is being referred to more favorably in the news media.

Company Overall Sentiment
Jin Medical International Neutral
Inogen Positive

Jin Medical International has a beta of 16.25, suggesting that its share price is 1,525% more volatile than the S&P 500. Comparatively, Inogen has a beta of 1.04, suggesting that its share price is 4% more volatile than the S&P 500.

Jin Medical International has a net margin of 0.00% compared to Inogen's net margin of -28.30%. Jin Medical International's return on equity of 0.00% beat Inogen's return on equity.

Company Net Margins Return on Equity Return on Assets
Jin Medical InternationalN/A N/A N/A
Inogen -28.30%-45.37%-28.57%

Jin Medical International has higher earnings, but lower revenue than Inogen.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jin Medical International$19.82M15.56$2.88MN/AN/A
Inogen$315.66M0.68-$102.45M-$3.97-2.27

89.9% of Inogen shares are held by institutional investors. 1.0% of Inogen shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Inogen has a consensus price target of $7.00, suggesting a potential downside of 22.48%. Given Inogen's higher possible upside, analysts clearly believe Inogen is more favorable than Jin Medical International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jin Medical International
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Inogen
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Inogen received 386 more outperform votes than Jin Medical International when rated by MarketBeat users.

CompanyUnderperformOutperform
Jin Medical InternationalN/AN/A
InogenOutperform Votes
386
69.68%
Underperform Votes
168
30.32%

Summary

Inogen beats Jin Medical International on 8 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INGN vs. The Competition

MetricInogenSurgical appliances & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$214.19M$9.31B$5.10B$8.43B
Dividend YieldN/A1.10%7.52%4.16%
P/E Ratio-2.2723.31133.4116.50
Price / Sales0.6835.571,617.6575.90
Price / CashN/A25.3937.2033.56
Price / Book1.035.824.594.98
Net Income-$102.45M$181.29M$116.16M$224.69M
7 Day Performance-3.53%-3.99%-0.97%-0.51%
1 Month Performance-0.99%-5.64%5.32%3.32%
1 Year Performance69.42%2.29%33.76%25.51%

Inogen Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INGN
Inogen
2.5385 of 5 stars
$9.10
+0.8%
$7.00
-23.1%
+69.4%$215.84M$326.65M-2.29834Upcoming Earnings
ZJYL
Jin Medical International
N/A$2.00
-2.0%
N/A-78.4%$310M$20.13M0.00245Positive News
SMTI
Sanara MedTech
2.0861 of 5 stars
$33.00
+0.8%
$44.00
+33.3%
+23.9%$288.75M$64.99M-42.3160Upcoming Earnings
High Trading Volume
LAKE
Lakeland Industries
4.8787 of 5 stars
$18.59
-4.4%
$26.50
+42.5%
+33.5%$137.57M$124.69M77.461,750Dividend Announcement
Gap Down
High Trading Volume
NTRB
Nutriband
0.755 of 5 stars
$6.19
+0.3%
N/A+171.5%$68.77M$2.09M-7.6410Gap Down
APT
Alpha Pro Tech
N/A$5.59
+0.4%
N/A+42.5%$62.44M$61.23M13.63120
MLSS
Milestone Scientific
2.2348 of 5 stars
$0.81
+0.6%
$1.25
+55.3%
-5.3%$62.17M$9.83M-11.5030Analyst Forecast
COCH
Envoy Medical
3.565 of 5 stars
$2.79
+5.3%
$7.92
+183.8%
+123.8%$54.68M$320,000.000.0034Gap Down
High Trading Volume
RBOT
Vicarious Surgical
1.9286 of 5 stars
$7.91
-2.5%
$11.33
+43.3%
-32.5%$46.67MN/A-0.763Upcoming Earnings
News Coverage
CLGN
CollPlant Biotechnologies
1.9265 of 5 stars
$3.68
-2.1%
$11.00
+198.7%
-34.0%$42.16M$10.96M-2.3970Negative News
High Trading Volume
SPAI
Safe Pro Group Inc. Common Stock
N/A$2.17
-3.6%
N/AN/A$30.08MN/A0.0011Gap Down

Related Companies and Tools


This page (NASDAQ:INGN) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners